280
Participants
Start Date
April 30, 2004
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Rasburicase (SR29142)
30-min IV infusion
Allopurinol
Oral administration
New York Medical College, Valhalla
New York Methodist Hospital, Brooklyn
Roswell Park Cancer Institute, Buffalo
University of Rochester Medical Center, Rochester
University of Pennsylvania Health Systems, Philadelphia
Duke University Medical Center, Durham
University of Florida Health Science Center at Jacksonville, Jacksonville
Ochsner Clinic Foundation, New Orleans
University of Texas MD Anderson Cancer Center, Houston
Rocky Mountain Cancer Center, Denver
UCLA Medical Center, Los Angeles
Alta Bates Comprehensive Cancer Center, Berkeley
Oregon Health and Sciences University, Portland
Massachusetts General Hospital, Boston
Mary Babb Randolph Cancer Center, Morgantown
Lead Sponsor
Sanofi
INDUSTRY